NYSE · XPEV
XPeng financials
$9.47−4.82%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $10.97B | $5.60B | $4.33B | $3.89B | $3.30B |
| Gross profit | $2.07B | $800.9M | $63.7M | $447.7M | $412.6M |
| Gross margin | 18.9% | 14.3% | 1.5% | 11.5% | 12.5% |
| Operating income | -$396.1M | -$912.2M | -$1.54B | -$1.26B | -$1.04B |
| Net income | -$162.9M | -$793.3M | -$1.47B | -$1.32B | -$765.1M |
| Net margin | −1.5% | −14.2% | −33.8% | −34.0% | −23.2% |
| Diluted EPS | $-0.09 | $-0.42 | $-0.84 | $-0.77 | $-0.47 |
| EBITDA | -$57.1M | -$623.2M | -$1.27B | -$1.12B | -$940.9M |
| Operating cash flow | $1.18B | -$275.7M | $135.1M | -$1.19B | -$172.2M |
| Free cash flow | $729.3M | -$581.4M | -$173.8M | -$1.86B | -$806.3M |
| Diluted shares | 1,904.0M | 1,891.4M | 1,740.9M | 1,712.5M | 1,642.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $2.48B | $2.55B | $2.98B | $2.12B |
| Short-term investments | $459.9M | $102.9M | $110.4M | $2.41B |
| Total debt | $4.67B | $2.86B | $1.66B | $1.26B |
| Total assets | $14.75B | $11.33B | $11.89B | $10.36B |
| Total liabilities | $10.40B | $7.05B | $6.76B | $5.01B |
| Shareholders' equity | $4.34B | $4.28B | $5.13B | $5.35B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology